Table of Contents
Share At:
Listen Article:
0:00 /
0:00
Renal Cell Carcinoma Treatment with Sorafenib Tablet
Table of Contents
Amongst the many medicines that are used in the treatment of advanced renal cell carcinoma, sorafenib tablet is considered one of the most effective. However, there are some precautions associated with its use.
How are Sorafenib Tablet Prepared?
Increasing sorafenib tablet bioavailability increases the therapeutic window and helps to reduce drug resistance. The oral tyrosine kinase inhibitor is metabolized by the UGT1A9 and UGT1A1 pathways. It is also a polymorphic compound.
Sorafenib is usually taken twice a day. The dose should be taken on an empty stomach. Usually, it should be taken at least one hour before a high fat meal. It should be taken at the same time every day.
The tablet contains the sorafenib tosylate. The suspension is intended to have a concentration of 50 mg/mL. The suspension was selected on the basis of the approved adult dose of 400 mg. It was prepared from the commercially available tablets.
The tablets were prepared using a wet granulation method. Talc powder was used to prepare tablets. The tablets were crushed and then combined with microcrystalline cellulose powder by a geometric dilution technique.
What are the Precautions with Sorafenib Tablet?
Sorafenib is an expensive drug, and your doctor may ask you to fork out for a monthly prescription. The best way to go about this is to speak with your doctor about your options. He or she will also tell you when it is time to start taking the drug again. The best time to start is before your scheduled appointment. They will know best whether or not this drug is safe for a woman of childbearing age.
It comes as a tablet that should be taken with a glass of water. The tablet should be kept out of reach of children and stored in a cool, dry place.
Treatment of Advanced Renal Cell Carcinoma with Sorafenib Tablet
Several significant studies have been conducted on Sorafenib Tablet for the treatment of advanced renal cell carcinoma (mRCC). Sorafenib Tablet is an oral multitargeted kinase inhibitor that targets abnormal proteins. These proteins may be involved in tumor growth and spread. Sorafenib has activity against tyrosine protein kinases, a group of proteins that are essential for cell growth and survival.
The Bottom Line
Renal cell carcinoma in later stages is treated with sorafenib. Sorafenib is also used to treat a specific kind of thyroid cancer that has spread to other portions of the body and cannot be cured with radioiodine, as well as hepatocellular carcinoma that cannot be cured surgically. Sorafenib belongs to the group of drugs known as kinase inhibitors. It functions by preventing the functioning of a problematic protein that instructs cancer cells to proliferate. This slows the growth of cancerous cells.
